Article
The methylenetetrahydrofolate reductase (MTHFR) 677 C>T polymorphism increases the risk of developing chronic myeloid leukemia-a case-control study.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine - 1 Apr 2015
Bănescu Claudia, Iancu Mihaela, Trifa Adrian P, Macarie Ioan, Dima Delia, Dobreanu Minodora
Abstract excerpt
The methylenetetrahydrofolate reductase (MTHFR) 677 C>T and 1298 A>C polymorphisms are associated with variations in folate levels, a phenomenon linked to the development of various malignancies. The aim of this study was to investigate the influence of the 677 C>T and 1298 A>C polymorphisms in the MTHFR gene on the risk of developing chronic myeloid leukemia (CML). Our study included 151 patients with CML and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
